Insights on BD&L forecasting, rare disease modeling, and pharmaceutical revenue projections.
Rare disease forecasting is where pharmaceutical analysts earn their credibility — or lose it. Here is the patient-based forecasting framework for rare disease BD&L deal evaluation.
By The Pharmaceutical Forecasting Team
Read more